Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series |
Jan 2021 |
Annals of Hematology |
Aplastic Anemia |
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) |
Jan 2021 |
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia |
Jan 2021 |
Seminars in Hematology |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse |
Jan 2021 |
Clinical Lymphoma , Myeloma & Leukemia |
Myelodysplastic Syndromes (MDS) |
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study |
Jan 2021 |
Journal of clinical oncology: official journal of the American Society Clinical Oncology |
Myelodysplastic Syndromes (MDS) |
Current and emerging strategies for management of myelodysplastic syndromes |
Dec 2020 |
Blood reviews |
Myelodysplastic Syndromes (MDS) |
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium |
Dec 2020 |
Cancer Medicine |
Myelodysplastic Syndromes (MDS) |
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology |
Dec 2020 |
Journal of Managed care and specialty pharmacy |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs |
Dec 2020 |
Journal of Managed care and specialty pharmacy |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease |
Dec 2020 |
Journal of Managed care and specialty pharmacy |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |